Article
MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects.
Oncotarget - 1 Nov 2016
Xu Chaoyi, Zhu Jinhong, Fu Wen, Liang Zongwen, Song Shujie, Zhao Yuan, Lyu Lihua, Zhang Anqi, He Jing, Duan Ping
Abstract excerpt
Mouse double minute 4 (MDM4) is a p53-interacting oncoprotein that plays an important role in the p53 tumor suppressor pathway. The common rs4245739 A > C polymorphism creates a miR-191 binding site in the MDM4 gene transcript. Numerous studies have investigated the association between this MDM4 polymorphism and cancer risk, but have failed to reach a definitive conclusion. To address this issue, we conducted a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
